ZA991102B - Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery. - Google Patents

Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery.

Info

Publication number
ZA991102B
ZA991102B ZA9901102A ZA991102A ZA991102B ZA 991102 B ZA991102 B ZA 991102B ZA 9901102 A ZA9901102 A ZA 9901102A ZA 991102 A ZA991102 A ZA 991102A ZA 991102 B ZA991102 B ZA 991102B
Authority
ZA
South Africa
Prior art keywords
techniques
intravascular
gene
mediated angiogenesis
angiogenesis therapy
Prior art date
Application number
ZA9901102A
Other languages
English (en)
Inventor
H Kirk Hammond
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of ZA991102B publication Critical patent/ZA991102B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paints Or Removers (AREA)
ZA9901102A 1998-02-11 1999-02-11 Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery. ZA991102B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2177398A 1998-02-11 1998-02-11

Publications (1)

Publication Number Publication Date
ZA991102B true ZA991102B (en) 2000-03-31

Family

ID=21806073

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901102A ZA991102B (en) 1998-02-11 1999-02-11 Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery.

Country Status (11)

Country Link
EP (2) EP1695719A1 (https=)
JP (1) JP2002502885A (https=)
KR (1) KR20010015915A (https=)
CN (2) CN101186928A (https=)
AU (1) AU2663799A (https=)
CA (1) CA2320302A1 (https=)
EA (1) EA019099B1 (https=)
IL (1) IL137765A0 (https=)
NZ (1) NZ545047A (https=)
WO (1) WO1999040945A2 (https=)
ZA (1) ZA991102B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034208A1 (en) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US6752987B1 (en) 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
WO2000024415A2 (en) 1998-10-28 2000-05-04 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
EP1255822A2 (en) 1999-12-27 2002-11-13 The Regents Of The University Of California Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
WO2002002148A2 (en) * 2000-06-30 2002-01-10 Collateral Therapeutics, Inc. Dual recombinant gene therapy compositions and methods of use
JP2005052001A (ja) * 2001-07-05 2005-03-03 Takara Bio Inc 遺伝子治療剤
DE602006017071D1 (de) 2005-01-25 2010-11-04 Five Prime Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
GB2437893A (en) * 2006-07-25 2007-11-07 Celladon Corp Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
US8157760B2 (en) 2007-07-18 2012-04-17 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
WO2009105135A1 (en) 2008-02-19 2009-08-27 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
US20130096500A1 (en) * 2011-07-07 2013-04-18 Gabor Rubanyi Nucleic acid based cardiovascular therapeutics
US20140296769A1 (en) * 2013-03-28 2014-10-02 Silk Road Medical, Inc. Methods and Systems for Establishing Retrograde Carotid Arterial Blood Flow
WO2019089385A1 (en) 2017-11-02 2019-05-09 Silk Road Medical, Inc. Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001616B1 (ru) * 1995-02-28 2001-06-25 Зе Риджентс Оф Зи Юнивесити Оф Кэлифоньэ Способ лечения болезни сердца, способ лечения недостаточности периферических сосудов и способ ограничения доставки и экспрессии трансгенной конструкции в определенном органе или структуре
US5869230A (en) * 1995-03-30 1999-02-09 Beth Israel Hospital Association Gene transfer into the kidney
WO1999017807A1 (en) * 1997-10-08 1999-04-15 Cobra Therapeutics Ltd. Use of a vasoactive compound in the enhancement of gene delivery
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
CN1301181A (zh) 2001-06-27
JP2002502885A (ja) 2002-01-29
EA200000828A1 (ru) 2001-02-26
WO1999040945A3 (en) 1999-09-30
AU2663799A (en) 1999-08-30
CN101186928A (zh) 2008-05-28
NZ545047A (en) 2009-05-31
EP1695719A1 (en) 2006-08-30
CN100350979C (zh) 2007-11-28
IL137765A0 (en) 2001-10-31
KR20010015915A (ko) 2001-02-26
EA019099B1 (ru) 2014-01-30
WO1999040945A2 (en) 1999-08-19
CA2320302A1 (en) 1999-08-19
EP1053025A2 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
AU3342599A (en) Delivery catheter
EP0915721A4 (en) INTRAVASCULAR ADMINISTRATION BY ELECTROPORATION
ZA987839B (en) Combination therapy.
ZA99877B (en) Inhalant medicator.
ZA971324B (en) Powdered medication inhaler.
ZA987844B (en) Therapeutic combinations.
ZA989061B (en) Medicaments.
EP1011787A4 (en) INTRAVASCULAR RADIATION DELIVERY SYSTEM
SI0901341T1 (en) Bend-responsive catheter
ZA975065B (en) Delivery needle.
ZA987843B (en) Combination therapy.
ZA961587B (en) Gene transfer-mediated angiogenesis therapy
IL117309A0 (en) Gene transfer-mediated angiogenesis therapy
EP0938352A4 (en) DRAINAGE CATHETER INSTALLATION SYSTEM
IL136774A0 (en) Medication delivery apparatus
MXPA02001088A (es) 2-pirazolin-5-onas..
ZA200104280B (en) Pharmaceutical combination preparations.
ZA97976B (en) Uniform drug delivery theraphy.
ZA99283B (en) Inhaler for medication.
ZA991102B (en) Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery.
ZA971272B (en) Gene expression.
ZA99880B (en) Inhalant medicator.
GB2359267B (en) Aroma therapy delivery system
GB9811691D0 (en) Flavour delivery systems
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.